AxoGen (AXGN) Competitors $18.77 -0.03 (-0.16%) As of 12:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AXGN vs. PRCT, NVST, TMDX, SLNO, LIVN, ENOV, NVCR, WRBY, LMAT, and CNMDShould you be buying AxoGen stock or one of its competitors? The main competitors of AxoGen include PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), Warby Parker (WRBY), LeMaitre Vascular (LMAT), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. AxoGen vs. PROCEPT BioRobotics Envista TransMedics Group Soleno Therapeutics LivaNova Enovis NovoCure Warby Parker LeMaitre Vascular CONMED AxoGen (NASDAQ:AXGN) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations. Does the MarketBeat Community believe in AXGN or PRCT? AxoGen received 417 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 68.97% of users gave PROCEPT BioRobotics an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45772.89% Underperform Votes17027.11% PROCEPT BioRoboticsOutperform Votes4068.97% Underperform Votes1831.03% Do analysts rate AXGN or PRCT? AxoGen currently has a consensus price target of $22.60, indicating a potential upside of 20.40%. PROCEPT BioRobotics has a consensus price target of $94.29, indicating a potential upside of 53.43%. Given PROCEPT BioRobotics' higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Do institutionals & insiders have more ownership in AXGN or PRCT? 80.3% of AxoGen shares are owned by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 7.0% of AxoGen shares are owned by company insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation & earnings, AXGN or PRCT? AxoGen has higher earnings, but lower revenue than PROCEPT BioRobotics. AxoGen is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M4.44-$21.72M-$0.22-85.32PROCEPT BioRobotics$224.50M15.01-$105.90M-$1.76-34.91 Is AXGN or PRCT more profitable? AxoGen has a net margin of -7.91% compared to PROCEPT BioRobotics' net margin of -50.07%. AxoGen's return on equity of -14.91% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% PROCEPT BioRobotics -50.07%-38.57%-26.06% Does the media prefer AXGN or PRCT? In the previous week, PROCEPT BioRobotics had 6 more articles in the media than AxoGen. MarketBeat recorded 15 mentions for PROCEPT BioRobotics and 9 mentions for AxoGen. AxoGen's average media sentiment score of 0.78 beat PROCEPT BioRobotics' score of 0.74 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 8 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, AXGN or PRCT? AxoGen has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. SummaryAxoGen and PROCEPT BioRobotics tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXGN vs. The Competition Export to ExcelMetricAxoGenElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$833.62M$3.25B$5.63B$8.12BDividend YieldN/A1.63%4.56%4.02%P/E Ratio-58.7514.9824.5319.04Price / Sales4.4441.93380.0592.99Price / CashN/A44.0938.1634.64Price / Book8.453.476.954.34Net Income-$21.72M$89.74M$3.20B$247.23M7 Day Performance4.05%-0.64%-2.28%-0.58%1 Month Performance-3.40%-8.17%3.09%-3.79%1 Year Performance141.57%-15.01%11.26%1.88% AxoGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXGNAxoGen2.6107 of 5 stars$18.77-0.2%$22.60+20.4%+149.0%$833.62M$187.34M-58.75450Short Interest ↓PRCTPROCEPT BioRobotics2.5032 of 5 stars$59.03+2.4%$94.29+59.7%+34.2%$3.24B$224.50M-30.27430NVSTEnvista4.1628 of 5 stars$17.16+3.0%$20.18+17.6%-15.5%$2.95B$2.51B-2.6412,700TMDXTransMedics Group2.6241 of 5 stars$67.69-1.2%$122.70+81.3%-5.6%$2.28B$441.54M72.01210Analyst ForecastSLNOSoleno Therapeutics4.4339 of 5 stars$49.63+0.6%$71.20+43.5%+13.4%$2.28BN/A-14.9530Analyst ForecastNews CoveragePositive NewsGap UpLIVNLivaNova4.049 of 5 stars$41.41+5.5%$61.17+47.7%-26.6%$2.25B$1.25B98.602,900Analyst UpgradePositive NewsENOVEnovis3.4624 of 5 stars$39.23+5.9%$58.50+49.1%-35.0%$2.23B$2.11B-17.916,550Positive NewsNVCRNovoCure3.7502 of 5 stars$19.59+0.5%$32.67+66.8%+41.1%$2.15B$605.22M-13.991,320WRBYWarby Parker2.9563 of 5 stars$20.35-0.5%$23.43+15.1%+52.5%$2.11B$771.32M-75.373,491LMATLeMaitre Vascular3.1206 of 5 stars$85.11+3.9%$95.25+11.9%+28.3%$1.92B$219.86M46.51490High Trading VolumeCNMDCONMED4.7589 of 5 stars$61.46+4.5%$77.20+25.6%-21.5%$1.90B$1.31B14.504,100Short Interest ↑Positive News Remove Ads Related Companies and Tools Related Companies PRCT Alternatives NVST Alternatives TMDX Alternatives SLNO Alternatives LIVN Alternatives ENOV Alternatives NVCR Alternatives WRBY Alternatives LMAT Alternatives CNMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AXGN) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AXGN Stock Free AXGN Stock Alerts